Aopwiki

SNAPSHOT

Created at: 2017-10-25 13:27

AOP ID and Title:


AOP 258: Renal protein alkylation leading to kidney toxicity
Short Title: Renal protein alkylation leading to kidney toxicity

Authors


Prof. Dr. Angela Mally
Department of Toxicology
University of Würzburg
Versbacher Str. 9
97078 Würzburg
Germany
Phone:  +49 931 31-81194
Email: mally@toxi.uni-wuerzburg.de (mailto:mally@toxi.uni-wuerzburg.de)


Status

Author status OECD status OECD project SAAOP status
Under development: Not open for comment. Do not cite

Abstract


It is well established that bioactivation of xenobiotics to reactive intermediates that covalently bind to proteins presents a major mechanism by which xenobiotics may cause proximal tubule injury. Examples for compounds that form covalent protein adducts in proximal tubule cells include haloalkenes (e.g. trichloroethylene, tetrachloroethylene, hexachloro-1,3-butadiene, chloroform), quinones (derived from e.g. hydroquinone, bromobenzene, 4-aminophenol), cephalosporins, and  N-(3,5-dichlorophenyl)succinimide [1-6]. Covalent interaction of a chemical or a metabolite with cellular proteins represents the molecular initiating event (MIE) that triggers perturbation of cellular functions, of which mitochondrial dysfunction (KE1) leading to ATP depletion (KE2) appears to be most critical for proximal tubule cell death (KE3) by apoptosis and/or necrosis [5, 7-10]. Tubular obstruction and  inflammatory responses to proximal tubule injury including activation of complement may cause secondary toxicity and thus amplify kidney injury, resulting in a progressive decline in kidney function (evidenced by e.g. rise in serum creatinine and blood urea nitrogen) (AO).



Summary of the AOP


Molecular Initiating Event

Title Short name
Alkylation, Protein Alkylation, Protein

244: Alkylation, Protein

Short Name: Alkylation, Protein

Key Event Component

Process Object Action
protein alkylation increased

AOPs Including This Key Event

AOP ID and Name Event Type
38: Protein Alkylation leading to Liver Fibrosis MolecularInitiatingEvent
258: Renal protein alkylation leading to kidney toxicity MolecularInitiatingEvent

Stressors

Name
Allyl Alcohol
Carbon tetrachloride
Retinol
Dimethyl nitrosamine
Thioacetamide

Biological Organization

Level of Biological Organization
Molecular

Cell term

Cell term
eukaryotic cell

Evidence for Perturbation by Stressor


Overview for Molecular Initiating Event

Two prototypical chemicals acting via protein alkylation are Allyl Alcohol [12][13][6][14][15] and Carbon Tetrachloride (CCl4)[11][16] [17] [18] [19][20][21][22] . [23] [24] .[25] [26]

Covalent protein alkylation is a feature of many cytotoxic drugs but the overall extent of binding does not adequately distinguish toxic from non-toxic binding. [27] Interestingly, some chemicals significantly alkylate proteins without causing toxicity, which suggests that only alkylation of a specific protein subset critical subset contributes to injury. Indeed, Codreanu presented an inventory of proteins affected by electrophile-mediated alkylation in intact cells and suggested that non-toxic covalent binding largely affects cytoskeletal protein components, whereas toxic covalent binding induces lethal injury by targeting factors involved in protein synthesis and catabolism and possibly mitochondrial electron transport. [3] In vitro covalent binding studies to macromolecules have been used to elucidate the biochemical mechanisms of chemical-induced toxicity. Experimental work with kidney epithelial cells by Chen et al suggested that following alkylation of cellular macromolecules as initial cytotoxic event both sulfhydryl depletion and lipid peroxidation are components of the cytotoxic mechanism [28] Dennehy et al have analyzed the protein targets in nuclear and cytoplasmic proteomes from human embryonic kidney cells (HEK293) treated in vitro with two biotin-tagged, thiol-reactive electrophiles and mapped the adducts. Certain protein families appeared particularly susceptible to alkylation. [29] Shin et al have identified protein targets of two biotin-tagged model electrophiles in human liver microsomes through LC-MS-MS and showed that different target selectivities of the two electrophile probes correlated with different biological outcomes and that alkylation reactions of specific targets could be quantified. [30]



Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
Rattus norvegicus Rattus norvegicus Strong NCBI
mouse Mus musculus Strong NCBI

Human, rat and mouse [11]


How this Key Event Works

Alkylation is the transfer of an alkyl group from one molecule to another. The alkyl group may be transferred as an alkyl carbocation, a free radical, a carbanion or a carbene (or their equivalents). Protein alkylation is the addition of an alkyl group to a protein amino acid. An alkyl group is any group derived from an alkane by removal of one hydrogen atom. Alkylating agents are highly reactive chemicals that introduce alkyl groups into biologically active molecules and thereby prevent their proper functioning. Alkylating agents are classified according to their nucleophilic or electrophilic character. Nucleophilic alkylating agents deliver the equivalent of an alkyl anion (carbanion). These compounds typically can add to an electron-deficient carbon atom such as at a carbonyl group. Electrophilic alkylating agents deliver the equivalent of an alkyl cation. Alkyl halides can also react directly with amines to form C-N bonds; the same holds true for other nucleophiles such as alcohols, carboxylic acids, thiols, etc. Alkylation with only one carbon is termed methylation. [1] [2]

Covalent protein alkylation by reactive electrophiles was identified as a key triggering event in chemical toxicity over 40 years ago and these reactions remain a major cause of chemical-induced toxicity. Interestingly, some chemical molecules produce significant protein covalent binding without causing toxicity, which suggests that only a critical subset of protein alkylation events contributes to injury. The study by Codreanu et al. (2014) describes an inventory of electrophile- mediated protein damage in intact cells and suggests that non-toxic covalent binding may largely be survivable damage to cytoskeletal components, whereas toxic covalent binding produces lethal injury by targeting protein synthesis and catabolism and possibly mitochondrial electron transport. [3] [4] [5] [6] [7]


How it is Measured or Detected


HPLC-ESI-MS/MS analysis

High Performance Liquid Chromatography – electrospray tandem mass spectrometry (HPLC-ESI-MS/MS) is the most popular MS technique. It combines the separation ability of HPLC along with the sensitivity and specificity of detection from MS. One of the advantages of HPLC-MS is that it allows samples to be rapidly desalted online, so no sample preparation is required unlike samples for GC-MS. Electrospray ionisation can produce singly or multiply charged ions. Typically high molecular weight compounds have multiple charges i.e. peptides and proteins. This technique is particularly suited to analysing polar molecules of mass <2000 Dalton and requires no prior derivatisation in most applications. [8] [3] [9]

MALDI-TOF/MS (Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry)

Matrix-assisted laser desorption/ionization (MALDI) is a soft ionization technique used in mass spectrometry, allowing the analysis of biomolecules (biopolymers such as DNA, proteins, peptides and sugars) and large organic molecules (such as polymers, dendrimers and other macromolecules), which tend to be fragile and fragment when ionized by more conventional ionization methods. MALDI methodology is a three-step process. First, the sample is mixed with a suitable matrix material and applied to a metal plate. Second, a pulsed laser irradiates the sample, triggering ablation and desorption of the sample and matrix material. Finally, the analyte molecules are ionized by being protonated or deprotonated in the hot plume of ablated gases, and can then be accelerated into whichever mass spectrometer is used to analyse them. [10]



References

  1. The European Bioinformatics Institute http://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0008213 (accessed on 20 January 2016).
  2. NLM, Medical Subject Headings, National Library of Medicine, http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&term=Alkylating+agents (accessed on 20 January 2016).
  3. 3.0 3.1 3.2 Codreanu, S.G. et al. (2014), Alkylation damage by lipid electrophiles targets functional protein systems, Molecular & Cellular Proteomics, vol. 13, no. 3, pp.849–859.
  4. Grattagliano, I. et al. (2009), Biochemical mechanisms in drug-induced liver injury: certainties and doubts, World J Gastroenterol, vol. 15, no. 39, pp. 4865-4876.
  5. Livertox http://livertox.nlm.nih.gov/AlkylatingAgents.htm
  6. 6.0 6.1 Kehrer, J.P. and S. Biswal (2000), The Molecular Effects of Acrolein, Toxicol. Sciences,vol.57,pp.6-15.
  7. Schopfer, F.J., C. Cipollina and B.A. Freeman (2011), Formation and Signaling Actions of Electrophilic Lipids, Chem Rev, vol. 111, no. 10,pp.5997–6021.
  8. Zhang F et al. (2005), Differential adduction of proteins vs. deoxynucleosides by methyl methanesulfonate and 1-methyl-1-nitrosourea in vitro, Mass Spectrom, vol 19, no. 4, pp. 438–448.
  9. Gundry, R.L. et al. (2009), Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow, Curr Protoc Mol Biol, chapter 10, section VI, unit 10.25, pp. 1-23.
  10. Kislinger, T. et al. (2005), Analysis of protein glycation products by MALDI-TOF/MS, Ann N Y Acad Sci, vol. 1043, pp. 249-259.
  11. 11.0 11.1 EPA Toxicological review of Carbon Tetrachloride (CAS No. 56-23-5). March 2010 EPA/635/R-08/005F available at: http://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/0020tr.pdf (accessed 24.10.2015)
  12. Auerbach, S.S. et al. (2008), A comparative 90 day toxicity study of allyl acetate, allyl alcohol and acrolein, Toxicology, Vol. 253, No.1-3, pp.79–88.
  13. Huang, L. et al. (2008), Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants, BMC Genomics, vol. 9: 288.
  14. Mohammad, M.K. et al. (2012), Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress, Toxicol Appl Pharmacol, vol. 265, no. 1, pp. 73-82.
  15. Yamada T et al., (2013), A category approach to predicting the repeated-dose hepatotoxicity of allyl esters, Regulatory Toxicology and Pharmacology, vol. 65, no. 2, pp. 189–195.
  16. Basu, S. (2003), Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients, Toxicology,vol.189, no.1-2, pp. 113-127.
  17. Calabrese, E.J., L.A. Baldwin and H.M. Mehendale (1993), G2 subpopulation in rat liver induced into mitosis by low-level exposure to carbon tetrachloride: an adaptive response, Toxicol Appl Pharmacol, vol. 121. no. 1, pp. 1-7.
  18. Clawson, G.A. (1989), Mechanisms of carbon tetrachloride hepatotoxicity, Pathol Immunopathol Res, vol. 8, no. 2, pp.104-112.
  19. Knockaert, L. et al. (2012), Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver, Lab Invest, vol. 92, no. 3, pp. 396-410.
  20. Lee Kwang-Jong et al. (2004), Induction of molecular chaperones in carbon tetrachloride-treated rat liver: implications in protection against liver damage, Cell Stress Chaperones, vol. 9, no. 1, pp. 58-68.
  21. Li, Xiaowei et al. (2014), NMR-based metabonomic and quantitative real-time PCR in the profiling of metabolic changes in carbon tetrachloride-induced rat liver injury, J Pharm Biomed Anal; vol. 89, pp.42-49.
  22. Manibusan, M.K., M. Odin and D.A. Eastmond (2007), Postulated carbon tetrachloride mode of action: a review, J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, vol. 25, no. 3,pp. 185-209.
  23. Masuda, Y. (2006), [Learning toxicology from carbon tetrachloride-induced hepatotoxicity],Yakugaku Zasshi, vol. 126, no. 10, pp. 885-899.
  24. Nagano, K. et al. (2007), Inhalation carcinogenicity and chronic toxicity of carbon tetrachloride in rats and mice, Inhal Toxicol, vol 19, no. 13, pp. 1089-1103.
  25. Recknagel, R.O. (1976), Carbon tetrachloride hepatotoxicity, Pharmacol Rev, vol. 19, no. 2,pp.145-208.
  26. Weber, L.W., M. Boll and A. Stampfl (2003), Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model, Crit Rev Toxicol, vol. 33, no. 2, pp. 105-136.
  27. Bauman, J.N. et al. (2009), Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction, Chem Res Toxicol, vol. 22, no. 2, pp. 332-340.
  28. Chen, Q. et al. (1990), The mechanism of cysteine conjugate cytotoxicity in renal epithelial cells. Covalent binding leads to thiol depletion and lipid peroxidation, J Biol Chem, vol. 265, no. 35, pp. 21603-21611.
  29. Dennehy, M.K. et al. (2006), Cytosolic and nuclear protein targets of thiol-reactive electrophiles, Chem Res Toxicol, vol. 19, no. 1, pp. 20-29.
  30. Shin, N.Y. et al. (2007), Protein targets of reactive electrophiles in human liver microsomes, Chem Res Toxicol, vol. 20, no. 6, pp. 859-867.

Key Events

Title Short name
Dysfunction, Mitochondria Dysfunction, Mitochondria
Decrease, Mitochondrial ATP production Decrease, Mitochondrial ATP production
Increase, Cytotoxicity (renal tubular cell) Increase, Cytotoxicity (renal tubular cell)

1483: Dysfunction, Mitochondria

Short Name: Dysfunction, Mitochondria

Biological Organization

Level of Biological Organization
Cellular

40: Decrease, Mitochondrial ATP production

Short Name: Decrease, Mitochondrial ATP production

Key Event Component

Process Object Action
ATP biosynthetic process ATP decreased

Biological Organization

Level of Biological Organization
Cellular

Cell term

Cell term
eukaryotic cell

709: Increase, Cytotoxicity (renal tubular cell)

Short Name: Increase, Cytotoxicity (renal tubular cell)

Key Event Component

Process Object Action
cell death kidney tubule cell increased

Biological Organization

Level of Biological Organization
Cellular

Cell term

Cell term
kidney tubule cell

Adverse Outcomes

Title Short name
Occurrence, Kidney toxicity Occurrence, Kidney toxicity

814: Occurrence, Kidney toxicity

Short Name: Occurrence, Kidney toxicity

Key Event Component

Process Object Action
toxicity kidney occurrence

Biological Organization

Level of Biological Organization
Organ

Organ term

Organ term
kidney

Scientific evidence supporting the linkages in the AOP

Upstream Event Relationship Type Downstream Event Evidence Quantitative Understanding
Alkylation, Protein directly leads to Dysfunction, Mitochondria Not Specified Weak
Dysfunction, Mitochondria directly leads to Decrease, Mitochondrial ATP production Strong Weak
Decrease, Mitochondrial ATP production directly leads to Increase, Cytotoxicity (renal tubular cell) Strong Weak
Increase, Cytotoxicity (renal tubular cell) directly leads to Occurrence, Kidney toxicity Strong Moderate

Overall Assessment of the AOP


Domain of Applicability

Life Stage Applicability
Life Stage Evidence
All life stages Not Specified
Taxonomic Applicability
Term Scientific Term Evidence Links
Human, rat, mouse Human, rat, mouse Strong NCBI
Sex Applicability
Sex Evidence
Unspecific Strong

Weight of Evidence Summary

Concordance of dose-response relationships

This is still a qualitiative description of the pathway. There is at present no quantitative information on dose-response relationships. Experiments are underway to provide quantitative understanding of dose-response relationships and response-response relationships between upstream and downstream KEs.

 

Temporal concordance among the key events and adverse outcome

The individual KEs are shown to occur prior to or concomitant with the onset of nephrotoxicity.

 

Strength, consistency, and specificity of association of adverse outcome and initiating event

The scientific evidence on the association between protein alkylation by reactive intermediates and kidney toxicity (AO) is strong and consistent. The MIE is not specific for kidney toxicity and is well established to lead to damage to other organs, whereby the site of toxicity is largely determined by the toxicokinetics of the parent compound or active metabolite.

 

Biological plausibility, coherence, and consistency of the experimental evidence

The described AOP is biologically plausible, coherent and well supported by experimental data.

 

Alternative mechanism(s) that logically present themselves and the extent to which they may distract from the postulated AOP

There are no alternative mechanism(s) that logically present themselves, although a contribution of other mechanisms such as generation of oxidative stress to the overall AO is possible.

 

Uncertainties, inconsistencies and data gaps

This AOP is plausible and consistent with general biological knowledge. However, there is currently little understanding as to which target proteins are critical to toxicity mediated by alkalation damage. Quantitative information on dose response-relationships as well as response-response relationships for upstream and downstream KEs is needed to support its applicability for the development of alternative in vitro tests for nephrotoxicity testing.

Quantitative Consideration

Quantitative data on KERs between upstream and downstream KE are still lacking.

Considerations for Potential Applications of the AOP (optional)


The described AOP is intended to provide a mechanistic framework for the development of in vitro bioactivity assays capable of predicting quantitative points of departure for safety assessment with regard to nephrotoxicity. Such assays may form part of an integrated testing strategy to reduce the need for repeated dose toxicity studies (e.g.  OECD Guideline 407; OECD Guideline 407).

References


1.           Birner, G., et al., Metabolism of tetrachloroethene in rats: identification of N epsilon-(dichloroacetyl)-L-lysine and N epsilon-(trichloroacetyl)-L-lysine as protein adducts. Chem Res Toxicol, 1994. 7(6): p. 724-32.

2.           Pahler, A., et al., Generation of antibodies to Di- and trichloroacetylated proteins and immunochemical detection of protein adducts in rats treated with perchloroethene. Chem Res Toxicol, 1998. 11(9): p. 995-1004.

3.           Kleiner, H.E., et al., Immunochemical detection of quinol--thioether-derived protein adducts. Chem Res Toxicol, 1998. 11(11): p. 1283-90.

4.           Lau, S.S., Quinone-thioether-mediated nephrotoxicity. Drug Metab Rev, 1995. 27(1-2): p. 125-41.

5.           Tune, B.M., Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention. Pediatr Nephrol, 1997. 11(6): p. 768-72.

6.           Griffin, R.J. and P.J. Harvison, In vivo metabolism and disposition of the nephrotoxicant N-(3, 5-dichlorophenyl)succinimide in Fischer 344 rats. Drug Metab Dispos, 1998. 26(9): p. 907-13.

7.           Groves, C.E., et al., Pentachlorobutadienyl-L-cysteine (PCBC) toxicity: the importance of mitochondrial dysfunction. J Biochem Toxicol, 1991. 6(4): p. 253-60.

8.           Chen, Y., et al., Role of mitochondrial dysfunction in S-(1,2-dichlorovinyl)-l-cysteine-induced apoptosis. Toxicol Appl Pharmacol, 2001. 170(3): p. 172-80.

9.           Hill, B.A., T.J. Monks, and S.S. Lau, The effects of 2,3,5-(triglutathion-S-yl)hydroquinone on renal mitochondrial respiratory function in vivo and in vitro: possible role in cytotoxicity. Toxicol Appl Pharmacol, 1992. 117(2): p. 165-71.

10.        Aleo, M.D., et al., Toxicity of N-(3,5-dichlorophenyl)succinimide and metabolites to rat renal proximal tubules and mitochondria. Chem Biol Interact, 1991. 78(1): p. 109-21.